SEC Form 4 · accession 0001730463-26-000131
Autolus Therapeutics plc · AUTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cintia Piccina
Officer — U.S. CCO & Country Gen Manager
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001730463
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Sep 1, 2026 | M | 20,000 | $2.35 | A | 20,000 | D | |
| American Depositary Shares | Sep 2, 2026 | S | 6,713 | $2.336 | D | 13,287 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1,F2 | — | Sep 1, 2026 | M | 20,000 | D | — | — | American Depositary Shares | 20,000 | 60,000 | D |
Explanation of responses
- F1Each RSU represents a contingent right to receive one Issuer American Depositary Share.
- F2The restricted share units ("RSUs") vest in four equal annual installments commencing on September 1, 2026.